Break it Down: Optiscan progresses real-time telepathology platform to minimum viable product stage
Stockhead's Break it Down brings you today's leading market news in under 90 seconds.
In this episode, host Tylah Tully looks at the latest from Optiscan (ASX:OIL), who have progressed its cloud-based telepathology streaming software project to minimum viable product stage.
Watch the video to find out the latest.
While Opitscan is a Stockhead advertiser, it did not sponsor this content.
Originally published as Break it Down: Optiscan progresses real-time telepathology platform to minimum viable product stage Stockhead
Copper's running hot and Telstra's chasing better returns, as markets ride a tariff breather out of Europe. Stockhead
Optiscan and its Canadian partner are at the advanced stage of developing software that will enable surgeons to 'talk' to remote pathologists in real time. Stockhead
American West Metals has raised almost $6 million to add to its funding pool to advance the Storm project in Canada.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
News.com.au
2 hours ago
- News.com.au
Germany's Merz survives Trump test, despite Ukraine differences
German Chancellor Friedrich Merz came through his Oval Office encounter with Donald Trump relatively unscathed Thursday -- despite differences over Ukraine as the US president said it might be better to let Moscow and Kyiv fight it out like children. A month into his job, Merz unleashed a charm offensive on the 78-year-old Trump, presenting him with a framed copy of the birth certificate of his grandfather Frederick, who was born in Germany in 1869. Merz also hailed Trump as being the "key person in the world" when it came to ending the Ukraine war, saying the US leader could "really do that now by putting pressure on Russia." It was a backhanded way of urging Trump to overcome his aversion to putting sanctions on Russia over its February 2022 invasion of Ukraine, as the more than three-year-old war grinds on. The polite meeting showed that the conservative German leader had done his homework as he sought to avoid ambushes like those that Trump unleashed on Ukraine's President Volodymyr Zelensky and South Africa's president. But they did not see eye to eye on everything. - 'Fighting in a park' - Trump -- who spoke to Russian leader Vladimir Putin a day earlier -- said it might be better to let the two sides fight it out, comparing the war that has left thousands dead and swathes of Ukraine in ruins to a children's brawl. "Sometimes you see two young children fighting like crazy. They hate each other, and they're fighting in a park, and you try and pull them apart," Trump told reporters. "Sometimes you're better off letting them fight for a while." Trump said however that he had urged Putin not to retaliate after Ukraine launched daring drone attacks on its airbases, destroying several nuclear capable bombers. "I said 'don't do it,'" Trump told reporters, adding that Putin had told him he had no choice but to respond and it was "not going to be pretty." Trump did make a series of off-color references to the defeat of Nazi Germany in World War II -- still a deeply sensitive subject in modern-day Germany. Praising Merz for Germany raising its defense spending in line with his demands for NATO members to cough up, Trump said he was not sure World War II US general Douglas MacArthur would have agreed. Then, referring to the upcoming 80th anniversary of the allied D-Day landings that led to the end of the war, Trump said: "That was not a pleasant day for you?" Merz, 69, calmly replied: "This was the liberation of my country from Nazi dictatorship. We know what we owe you." - Tariffs deal possible - Merz avoided other possible pitfalls as Trump spent much of his time on a lengthy discourse against his billionaire former advisor Elon Musk. Topics like US tariffs on the EU and the prospect of a trade deal barely came up, with Trump saying he believed a deal was possible. On Trump's threat to hammer the European Union with sharply higher tariffs, Merz, leader of the bloc's biggest economy, had earlier argued that it must be self-confident in its negotiations with Washington. Nor did Trump confront Merz over free speech issues in Germany as US media had reported he might -- a bugbear the administration has repeatedly brought up with European leaders despite its own record. Merz told reporters in Washington ahead of the meeting that if Trump brought up German domestic politics "I will state my opinion very clearly if necessary." Trump and some in his administration have given vocal support to the far-right and anti-immigration Alternative for Germany (AfD) party, which came second in February elections. US Vice President JD Vance, Secretary of State Marco Rubio and former Trump adviser Elon Musk have all weighed in in support of the AfD, which in Germany is shunned by all other political parties. Despite the tensions, Merz had said earlier that he was "looking forward" to his first face-to-face meeting with Trump. The German chancellor is believed to have studied videos of previous Oval Office ambushes and learned how to stay calm and let Trump talk.
News.com.au
5 hours ago
- News.com.au
ECB cuts rates again but pause seen ahead
President Christine Lagarde said the European Central Bank was in a "good place" to deal with global uncertainty as it cut interest rates again Thursday, fuelling expectations it might soon hit pause after a lengthy easing cycle. The ECB cut its key deposit rate a quarter point to two percent, as widely expected, its seventh consecutive reduction and eighth since June last year when it began lowering borrowing costs. It also lowered its inflation forecast, with the indicator now expected to hit the central bank's two-percent target this year, as US President Donald Trump's tariff blitz exerts downward pressure on prices. As inflation has stabilised following a post-pandemic surge, the ECB has shifted its focus to dialling back borrowing costs to relieve pressure on the 20 countries that use the euro. Trump's tariffs have added to the uncertain outlook, with Europe firmly in his crosshairs, fuelling fears about a heavy hit to the continent's exporters. But Lagarde struck a measured tone. While the US trade war was causing problems, she noted signs of growing strength in the eurozone economy as well as a potential future boost from plans for greater infrastructure and defence spending. She refused to comment directly about whether the ECB would pause its cuts at its next meeting in July, as some expect, but she stressed repeatedly that the central bank was in a "good place". "We are in a good position to navigate the uncertain conditions that will be coming up," she said. "I think we are getting to the end of a monetary policy cycle," she added. The ECB left its growth forecast for 2025 unchanged at 0.9 percent, and also noted inflation was now around its two-percent target -- dropping previous language that it was "on track". Eurozone inflation came in at 1.9 percent in May. - 'Summer pause' - ING bank analyst Carsten Brzeski said Lagarde's comments signalled a "summer pause" to its rate cuts. "It will take a bit longer to understand whether the current disinflationary risks are merely one-offs or whether they signal a broader trend," he said. But he added he expected one more cut from the central bank this year, likely in September. The ECB's series of cuts stands in contrast to the US Federal Reserve, which has kept rates on hold recently amid fears that Trump's levies could stoke inflation in the world's top economy. Lagarde also knocked back suggestions she could cut her term short following reports she had discussed taking the helm of the World Economic Forum. "I have always been and I'm fully determined to deliver on my mission and I'm determined to complete my term," she said. - Trump tariffs blitz - Trump, who argues his tariffs will bring manufacturing jobs back to the United States, has already hit the EU with multiple waves of levies. The bloc currently faces a 10-percent "baseline" tariff as well as higher duties on specific sectors. He has paused even higher rates on the EU and other trading partners to allow for talks, but he continues to launch fresh salvos that are keeping the world on edge. This week he doubled tariffs on aluminium and steel from 25 to 50 percent and last month threatened the EU with an escalation if it did not negotiate a swift deal. Trump's tariffs are expected to exert downward pressure on eurozone consumer prices, and Lagarde conceded the inflation outlook was "more uncertain than usual". This is due to factors including tariff-hit China redirecting inexpensive manufactured goods to Europe, recent strengthening of the euro and potentially lower energy prices. Lower inflation and still tepid growth should push the ECB to make further rate cuts. There are some factors that make this uncertain though. These include signs of resilience in the eurozone economy at the start of the year and a potentially inflationary spending blitz planned by the new German government.
ABC News
6 hours ago
- ABC News
UK medicine regulator warns that women taking Mounjaro, Ozempic need to use effective contraception
Women in the UK have been urged to use effective contraception if they are using weight loss drugs after dozens of reports of unintentional pregnancies from people taking the medication. The Medicines and Healthcare products Regulatory Agency (MHRA) warning said women taking popular "skinny jabs" like Ozempic, Mounjaro and Wegovy should "use a barrier form of contraception and do not rely on oral contraception." The warning comes after the agency received 40 reports relating to unintended pregnancies while using such weight loss drugs. Ying Cheong, a consultant in reproductive medicine at the University of Southampton, called the MHRA's advice "both timely and necessary". "Gastrointestinal side-effects such as vomiting and diarrhoea can impair oral contraceptive absorption, increasing the risk of unintended pregnancy," she said. The warning from the MHRA urged women to use "effective contraception while taking these medicines and, in some cases, for up to two months between stopping the medicine and trying to get pregnant." It also made clear that these drugs "must not be taken during pregnancy, while trying to get pregnant, or during breastfeeding." "Anyone who gets pregnant while using them should speak to their healthcare professional and stop the medicine as soon as possible… because there is not enough safety data to know whether taking the medicine could cause harm to the baby," it added. Dr Alison Cave, MHRA Chief Safety Officer said "skinny jabs are medicines licensed to treat specific medical conditions and should not be used as aesthetic or cosmetic treatments." Rebecca Reynolds, a professor of metabolic medicine at the University of Edinburgh, said there was "hardly any available data from human studies" to know if the weight loss drugs were safe in pregnancy. "The data from animal studies suggests the potential for harm with low birth-weight and skeletal abnormalities, though more evidence is needed to assess if there are risks of taking these drugs in humans," she added. The MHRA also warned about the impact of another weight-loss and diabetes injection, Mounjaro, on the effectiveness of oral contraception for people who are overweight. "Those taking Mounjaro who are overweight and are using an oral form of contraception are advised to also use a non-oral form of contraception," it said. The MHRA also added a reminder to people that these medicines "should not be bought from unregulated sellers such as beauty salons or via social media", or taken without a a prescription from a doctor. "Not only does this expose people wanting to lose weight to serious health risks, it is also against the law to sell these medicines in this way," the statement said. ABC/AFP
